Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Amgen reports Q3 total product sales up 12% y/y » 17:37
10/28/20
10/28
17:37
10/28/20
17:37
AMGN

Amgen

$216.61 /

-6.78 (-3.04%)

Total product sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$216.61 /

-6.78 (-3.04%)

AMGN Amgen
$216.61 /

-6.78 (-3.04%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$216.61 /

-6.78 (-3.04%)

AMGN Amgen
$216.61 /

-6.78 (-3.04%)

AMGN Amgen
$216.61 /

-6.78 (-3.04%)

AMGN Amgen
$216.61 /

-6.78 (-3.04%)

Hot Stocks
Amgen sees FY20 share repurchases at lower end of $3B-$5B range  16:03
10/28/20
10/28
16:03
10/28/20
16:03
AMGN

Amgen

$217.70 /

-5.69 (-2.55%)

 
ShowHide Related Items >><<
AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

10/28/20 UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

Earnings
Amgen raises FY20 adjusted EPS view to $15.80-$16.15 from $15.10-$15.75 » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
AMGN

Amgen

$217.45 /

-5.94 (-2.66%)

FY20 consensus $15.77.…

FY20 consensus $15.77. Narrows FY20 revenue view to $25.1B-$25.5B from $25B-$25.6B, consensus $25.41B.

ShowHide Related Items >><<
AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

10/28/20 UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

Earnings
Amgen reports Q3 adjusted EPS $4.37, consensus $3.80 » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
AMGN

Amgen

$217.77 /

-5.62 (-2.52%)

Reports Q3 revenue $6.4B,…

Reports Q3 revenue $6.4B, consensus $6.35B.

ShowHide Related Items >><<
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

10/28/20 UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

Earnings
Notable companies reporting after market close » 13:05
10/28/20
10/28
13:05
10/28/20
13:05
V

Visa

$179.46 /

-10.54 (-5.55%)

, AMGN

Amgen

$217.63 /

-5.76 (-2.58%)

, NOW

ServiceNow

$481.00 /

-18.74 (-3.75%)

, GILD

Gilead

$58.56 /

-1.46 (-2.43%)

, CTSH

Cognizant

$71.59 /

-1.78 (-2.43%)

, EBAY

eBay

$53.00 /

-0.58 (-1.08%)

, ORLY

O'Reilly Automotive

$444.81 /

-5.2 (-1.16%)

, F

Ford

$7.73 /

-0.195 (-2.46%)

, PINS

Pinterest

$49.58 /

-3 (-5.71%)

, YUMC

Yum China

$52.40 /

-1.595 (-2.95%)

, CERN

Cerner

$71.50 /

-1.24 (-1.70%)

, TDOC

Teladoc

$225.25 /

+2.67 (+1.20%)

, ETSY

Etsy

$139.20 /

-6.69 (-4.59%)

, LVGO

Livongo Health

$144.33 /

+1.4 (+0.98%)

, WDC

Western Digital

$39.03 /

-1.27 (-3.15%)

, URI

United Rentals

$169.09 /

-5.89 (-3.37%)

, MOH

Molina Healthcare

$195.71 /

-8.49 (-4.16%)

, FSLY

Fastly

$71.30 /

-3.1 (-4.17%)

, SPWR

SunPower

$15.73 /

+0.23 (+1.48%)

, SFM

Sprouts Farmers Market

$20.38 /

-0.035 (-0.17%)

, NOVA

Sunnova Energy

$26.37 /

+0.07 (+0.27%)

, RCII

Rent-A-Center

$31.83 /

-0.54 (-1.67%)

, SAVE

Spirit Airlines

$15.64 /

-0.9 (-5.44%)

Notable companies…

Notable companies reporting after the market close, with earnings consensus, include Visa (V), consensus $1.10... Amgen (AMGN), consensus $3.80... ServiceNow (NOW), consensus $1.03... Gilead Sciences (GILD), consensus $1.95... Cognizant Technology (CTSH), consensus 90c... eBay Inc. (EBAY), consensus 86c... O'Reilly Automotive (ORLY), consensus $6.19... Ford Motor (F), consensus 16c... Pinterest (PINS), consensus 2c... Yum China (YUMC), consensus 49c... Cerner (CERN), consensus 71c... Teladoc Health (TDOC), consensus (32c)... Etsy (ETSY), consensus 58c... Livongo Health (LVGO), consensus 5c... Western Digital (WDC), consensus 54c... United Rentals (URI), consensus $4.28... Molina Healthcare (MOH), consensus $2.16... Fastly (FSLY), consensus 0c... SunPower (SPWR), consensus (5c)... Sprouts Farmers Market (SFM), consensus 36c... Sunnova Energy (NOVA), consensus (15c)... Rent-A-Center (RCII), consensus 96c... Spirit Airlines (SAVE), consensus ($2.72).

ShowHide Related Items >><<
YUMC Yum China
$52.40 /

-1.595 (-2.95%)

WDC Western Digital
$39.03 /

-1.27 (-3.15%)

V Visa
$179.46 /

-10.54 (-5.55%)

URI United Rentals
$169.09 /

-5.89 (-3.37%)

TDOC Teladoc
$225.25 /

+2.67 (+1.20%)

SPWR SunPower
$15.73 /

+0.23 (+1.48%)

SFM Sprouts Farmers Market
$20.38 /

-0.035 (-0.17%)

SAVE Spirit Airlines
$15.64 /

-0.9 (-5.44%)

RCII Rent-A-Center
$31.83 /

-0.54 (-1.67%)

PINS Pinterest
$49.58 /

-3 (-5.71%)

ORLY O'Reilly Automotive
$444.81 /

-5.2 (-1.16%)

NOW ServiceNow
$481.00 /

-18.74 (-3.75%)

NOVA Sunnova Energy
$26.37 /

+0.07 (+0.27%)

MOH Molina Healthcare
$195.71 /

-8.49 (-4.16%)

LVGO Livongo Health
$144.33 /

+1.4 (+0.98%)

GILD Gilead
$58.56 /

-1.46 (-2.43%)

FSLY Fastly
$71.30 /

-3.1 (-4.17%)

F Ford
$7.73 /

-0.195 (-2.46%)

ETSY Etsy
$139.20 /

-6.69 (-4.59%)

EBAY eBay
$53.00 /

-0.58 (-1.08%)

CTSH Cognizant
$71.59 /

-1.78 (-2.43%)

CERN Cerner
$71.50 /

-1.24 (-1.70%)

AMGN Amgen
$217.63 /

-5.76 (-2.58%)

V Visa
$179.46 /

-10.54 (-5.55%)

10/21/20 Barclays
Visa price target raised to $235 from $225 at Barclays
10/05/20 Morgan Stanley
Repay Holdings initiated with an Equal Weight at Morgan Stanley
10/02/20 Jefferies
Visa price target raised to $205 from $185 at Jefferies
09/21/20 KeyBanc
Visa price target raised to $230 from $215 at KeyBanc
AMGN Amgen
$217.63 /

-5.76 (-2.58%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
NOW ServiceNow
$481.00 /

-18.74 (-3.75%)

10/26/20 Jefferies
Jefferies positive on ServiceNow ahead of Q3 results
10/26/20 Stifel
SAP news impact may be company-specific for software sector, says Stifel
10/26/20 Stifel
ServiceNow price target raised to $550 from $500 at Stifel
10/23/20 Credit Suisse
ServiceNow price target raised to $560 from $465 at Credit Suisse
GILD Gilead
$58.56 /

-1.46 (-2.43%)

06:28 Today UBS
Gilead initiated with a Neutral at UBS
10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
CTSH Cognizant
$71.59 /

-1.78 (-2.43%)

10/13/20 Susquehanna
Cognizant upgraded to Positive at Susquehanna
10/13/20 Susquehanna
Cognizant upgraded to Positive from Neutral at Susquehanna
09/11/20
Fly Intel: Top five analyst upgrades
09/11/20 BofA
Cognizant upgraded to Buy from Neutral at BofA
EBAY eBay
$53.00 /

-0.58 (-1.08%)

10/09/20 Mizuho
eBay price target raised to $55 from $52 at Mizuho
10/08/20 Piper Sandler
eBay 2022 revenue estimates remain too low, says Piper Sandler
09/30/20 Baird
eBay estimates raised on solid September data, says Baird
09/24/20 Piper Sandler
eBay assumed with an Overweight at Piper Sandler
ORLY O'Reilly Automotive
$444.81 /

-5.2 (-1.16%)

10/20/20 RBC Capital
O'Reilly Automotive price target raised to $560 from $541 at RBC Capital
10/19/20
Fly Intel: Top five analyst upgrades
10/19/20 Raymond James
O'Reilly Automotive upgraded to Outperform from Market Perform at Raymond James
10/19/20 Raymond James
O'Reilly Automotive upgraded to Outperform from Market Perform at Raymond James
F Ford
$7.73 /

-0.195 (-2.46%)

10/22/20 JPMorgan
Ford price target raised to $9 from $7 at JPMorgan
10/22/20 Barclays
Ford price target raised to $9 from $8 at Barclays
10/20/20 Citi
Ford price target raised to $9 from $7.50 at Citi
10/14/20 Goldman Sachs
Ford price target raised to $8 from $7 at Goldman Sachs
PINS Pinterest
$49.58 /

-3 (-5.71%)

10/26/20 JPMorgan
Pinterest price target raised to $57 from $37 at JPMorgan
10/26/20 KeyBanc
Pinterest price target raised to $60 from $44 at KeyBanc
10/22/20 OTR Global
Pinterest upgraded to Positive from Mixed at OTR Global
10/21/20
Fly Intel: Top five analyst upgrades
YUMC Yum China
$52.40 /

-1.595 (-2.95%)

09/10/20 Goldman Sachs
Yum China H-shares initiated with a Conviction Buy at Goldman Sachs
09/10/20 Goldman Sachs
Yum China H-shares initiated with a Conviction Buy at Goldman Sachs
08/06/20
Fly Intel: Top analyst initiations
08/06/20 CLSA
Yum China initiated with a Buy at CLSA
CERN Cerner
$71.50 /

-1.24 (-1.70%)

07/31/20 Deutsche Bank
Cerner price target raised to $77 from $72 at Deutsche Bank
07/06/20 Stephens
Cerner initiated with an Equal Weight at Stephens
06/15/20 Evercore ISI
Cerner assumed with an In Line at Evercore ISI
06/10/20 Lake Street
OptimizeRx news strategically significant, broadens reach, says Lake Street
TDOC Teladoc
$225.25 /

+2.67 (+1.20%)

05:02 Today Piper Sandler
Livongo Health downgraded to Neutral from Overweight at Piper Sandler
05:00 Today Piper Sandler
Teladoc price target raised to $305 from $232 at Piper Sandler
10/14/20 JPMorgan
Livongo Health downgraded to Neutral from Overweight at JPMorgan
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
ETSY Etsy
$139.20 /

-6.69 (-4.59%)

10/27/20 Deutsche Bank
Etsy price target raised to $159 from $156 at Deutsche Bank
10/22/20 Roth Capital
Etsy price target raised to $165 from $160 at Roth Capital
10/08/20 Oppenheimer
Etsy price target raised to $160 from $150 at Oppenheimer
10/07/20 Wedbush
Etsy remains a winner in ecommerce, says Wedbush
LVGO Livongo Health
$144.33 /

+1.4 (+0.98%)

09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
WDC Western Digital
$39.03 /

-1.27 (-3.15%)

10/19/20 Lynx
Intel/SK Hynix deal impact to Western, Micron 'manageable,' says Lynx
10/19/20 Wells Fargo
Western Digital positive reaction to Intel report justifiable, says Wells Fargo
10/19/20 KeyBanc
Potential NAND business sale 'favorable' for Intel and sector, says KeyBanc
09/28/20 Deutsche Bank
Deutsche Bank closes 'Buy Catalyst Call' on Western Digital
URI United Rentals
$169.09 /

-5.89 (-3.37%)

10/19/20 Barclays
United Rentals downgraded to Underweight with $173 target at Barclays
10/19/20 Barclays
United Rentals downgraded to Underweight from Equal Weight at Barclays
10/13/20 Deutsche Bank
United Rentals price target raised to $190 from $166 at Deutsche Bank
10/13/20 Deutsche Bank
United Rentals named 'Catalyst Call: Sell Idea' at Deutsche Bank
MOH Molina Healthcare
$195.71 /

-8.49 (-4.16%)

10/13/20 Truist
Truist raises price targets on select Healthcare Services names
09/30/20 Truist
Molina Healthcare risk-reward attractive after Affinity Health deal, says Truist
09/22/20 Stephens
Molina Healthcare downgraded to Equal Weight from Overweight at Stephens
09/21/20 Citi
Citi sees ACA remaining law despite Ginsburg death
FSLY Fastly
$71.30 /

-3.1 (-4.17%)

10/23/20
Fly Intel: Top five analyst downgrades
10/23/20 Piper Sandler
Piper downgrades Fastly to Underweight with TikTok becoming 'bigger issue'
10/23/20 Piper Sandler
Fastly downgraded to Underweight from Neutral at Piper Sandler
10/16/20 Craig-Hallum
Fastly price target lowered to $85 from $100 at Craig-Hallum
SPWR SunPower
$15.73 /

+0.23 (+1.48%)

10/27/20 UBS
SunPower downgraded to Sell from Neutral at UBS
10/27/20 UBS
SunPower downgraded to Sell from Neutral at UBS
10/26/20 Credit Suisse
SunPower downgraded to Neutral at Credit Suisse
10/26/20 Credit Suisse
SunPower downgraded to Neutral from Outperform at Credit Suisse
SFM Sprouts Farmers Market
$20.38 /

-0.035 (-0.17%)

10/20/20
Fly Intel: Top five analyst downgrades
10/20/20 Gordon Haskett
Sprouts Farmers Market downgraded to Hold from Buy at Gordon Haskett
08/06/20 Credit Suisse
Sprouts Farmers Market assumed with a Neutral at Credit Suisse
07/30/20
Fly Intel: Top five analyst initiations
NOVA Sunnova Energy
$26.37 /

+0.07 (+0.27%)

10/27/20 B. Riley Securities
Sunnova Energy price target raised to $33 from $30 at B. Riley Securities
10/26/20 Credit Suisse
Sunnova Energy price target raised to $38 from $26 at Credit Suisse
10/22/20 Baird
Baird a buyer of solar stocks insulated from supply chain disruptions
10/14/20 JMP Securities
Sunnova Energy price target raised to $55 from $43 at JMP Securities
RCII Rent-A-Center
$31.83 /

-0.54 (-1.67%)

10/12/20 Loop Capital
Rent-A-Center downgraded to Hold from Buy at Loop Capital
09/22/20 Loop Capital
Rent-A-Center Q3 guidance impressive amid receding tailwinds, says Loop Capital
08/07/20 Loop Capital
Rent-A-Center price target raised to $34 from $29 at Loop Capital
07/01/20
Fly Intel: Top five analyst downgrades
SAVE Spirit Airlines
$15.64 /

-0.9 (-5.44%)

10/08/20 Evercore ISI
Spirit Airlines upgraded to Outperform from In Line at Evercore ISI
10/07/20
Fly Intel: Top five analyst upgrades
10/07/20 JPMorgan
Spirit Airlines upgraded to Neutral from Underweight at JPMorgan
09/18/20 Barclays
Spirit Airlines price target raised to $24 from $18 at Barclays
YUMC Yum China
$52.40 /

-1.595 (-2.95%)

WDC Western Digital
$39.03 /

-1.27 (-3.15%)

V Visa
$179.46 /

-10.54 (-5.55%)

URI United Rentals
$169.09 /

-5.89 (-3.37%)

TDOC Teladoc
$225.25 /

+2.67 (+1.20%)

SPWR SunPower
$15.73 /

+0.23 (+1.48%)

SFM Sprouts Farmers Market
$20.38 /

-0.035 (-0.17%)

SAVE Spirit Airlines
$15.64 /

-0.9 (-5.44%)

RCII Rent-A-Center
$31.83 /

-0.54 (-1.67%)

PINS Pinterest
$49.58 /

-3 (-5.71%)

ORLY O'Reilly Automotive
$444.81 /

-5.2 (-1.16%)

NOW ServiceNow
$481.00 /

-18.74 (-3.75%)

NOVA Sunnova Energy
$26.37 /

+0.07 (+0.27%)

MOH Molina Healthcare
$195.71 /

-8.49 (-4.16%)

LVGO Livongo Health
$144.33 /

+1.4 (+0.98%)

GILD Gilead
$58.56 /

-1.46 (-2.43%)

FSLY Fastly
$71.30 /

-3.1 (-4.17%)

F Ford
$7.73 /

-0.195 (-2.46%)

ETSY Etsy
$139.20 /

-6.69 (-4.59%)

EBAY eBay
$53.00 /

-0.58 (-1.08%)

CTSH Cognizant
$71.59 /

-1.78 (-2.43%)

CERN Cerner
$71.50 /

-1.24 (-1.70%)

AMGN Amgen
$217.63 /

-5.76 (-2.58%)

  • 13
    Oct
  • 04
    Sep
  • 14
    Aug
  • 01
    Jul
  • 21
    May
  • 08
    May
  • 12
    Dec
  • 21
    Nov
YUMC Yum China
$52.40 /

-1.595 (-2.95%)

WDC Western Digital
$39.03 /

-1.27 (-3.15%)

V Visa
$179.46 /

-10.54 (-5.55%)

TDOC Teladoc
$225.25 /

+2.67 (+1.20%)

SFM Sprouts Farmers Market
$20.38 /

-0.035 (-0.17%)

SAVE Spirit Airlines
$15.64 /

-0.9 (-5.44%)

RCII Rent-A-Center
$31.83 /

-0.54 (-1.67%)

PINS Pinterest
$49.58 /

-3 (-5.71%)

MOH Molina Healthcare
$195.71 /

-8.49 (-4.16%)

GILD Gilead
$58.56 /

-1.46 (-2.43%)

F Ford
$7.73 /

-0.195 (-2.46%)

ETSY Etsy
$139.20 /

-6.69 (-4.59%)

EBAY eBay
$53.00 /

-0.58 (-1.08%)

CTSH Cognizant
$71.59 /

-1.78 (-2.43%)

AMGN Amgen
$217.63 /

-5.76 (-2.58%)

YUMC Yum China
$52.40 /

-1.595 (-2.95%)

WDC Western Digital
$39.03 /

-1.27 (-3.15%)

V Visa
$179.46 /

-10.54 (-5.55%)

TDOC Teladoc
$225.25 /

+2.67 (+1.20%)

SPWR SunPower
$15.73 /

+0.23 (+1.48%)

SFM Sprouts Farmers Market
$20.38 /

-0.035 (-0.17%)

SAVE Spirit Airlines
$15.64 /

-0.9 (-5.44%)

RCII Rent-A-Center
$31.83 /

-0.54 (-1.67%)

PINS Pinterest
$49.58 /

-3 (-5.71%)

NOW ServiceNow
$481.00 /

-18.74 (-3.75%)

NOVA Sunnova Energy
$26.37 /

+0.07 (+0.27%)

MOH Molina Healthcare
$195.71 /

-8.49 (-4.16%)

LVGO Livongo Health
$144.33 /

+1.4 (+0.98%)

GILD Gilead
$58.56 /

-1.46 (-2.43%)

FSLY Fastly
$71.30 /

-3.1 (-4.17%)

F Ford
$7.73 /

-0.195 (-2.46%)

ETSY Etsy
$139.20 /

-6.69 (-4.59%)

EBAY eBay
$53.00 /

-0.58 (-1.08%)

CTSH Cognizant
$71.59 /

-1.78 (-2.43%)

AMGN Amgen
$217.63 /

-5.76 (-2.58%)

WDC Western Digital
$39.03 /

-1.27 (-3.15%)

V Visa
$179.46 /

-10.54 (-5.55%)

URI United Rentals
$169.09 /

-5.89 (-3.37%)

TDOC Teladoc
$225.25 /

+2.67 (+1.20%)

SPWR SunPower
$15.73 /

+0.23 (+1.48%)

SFM Sprouts Farmers Market
$20.38 /

-0.035 (-0.17%)

SAVE Spirit Airlines
$15.64 /

-0.9 (-5.44%)

PINS Pinterest
$49.58 /

-3 (-5.71%)

NOVA Sunnova Energy
$26.37 /

+0.07 (+0.27%)

LVGO Livongo Health
$144.33 /

+1.4 (+0.98%)

GILD Gilead
$58.56 /

-1.46 (-2.43%)

FSLY Fastly
$71.30 /

-3.1 (-4.17%)

F Ford
$7.73 /

-0.195 (-2.46%)

ETSY Etsy
$139.20 /

-6.69 (-4.59%)

EBAY eBay
$53.00 /

-0.58 (-1.08%)

CTSH Cognizant
$71.59 /

-1.78 (-2.43%)

CERN Cerner
$71.50 /

-1.24 (-1.70%)

AMGN Amgen
$217.63 /

-5.76 (-2.58%)

Hot Stocks
Novartis announces collaboration with Molecular Partners on COVID-19 therapies » 06:54
10/28/20
10/28
06:54
10/28/20
06:54
NVS

Novartis

$80.94 /

-3.29 (-3.91%)

Novartis and Molecular…

Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners' anti-COVID-19 DARPin program, consisting of two therapeutic candidates, MP0420 and MP0423. "The collaboration aims to leverage Molecular Partners' proprietary DARPin technologies and Novartis broad expertise in global drug development, regulatory affairs, manufacturing and commercialization to rapidly advance the program in keeping with the unprecedented global urgency created by the pandemic," the company said. Under the terms of the agreement, Molecular Partners will receive an upfront payment of CHF 60M, including equity. Molecular Partners will receive a further payment of CHF 150M, upon Novartis electing to take up the option to both therapeutic candidates, and significant royalty on sales. Molecular Partners has agreed to forgo royalties in lower income countries, and is aligned with Novartis' plans to ensure affordability based on countries' needs and capabilities.

ShowHide Related Items >><<
NVS Novartis
$80.94 /

-3.29 (-3.91%)

NVS Novartis
$80.94 /

-3.29 (-3.91%)

10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
NVS Novartis
$80.94 /

-3.29 (-3.91%)

NVS Novartis
$80.94 /

-3.29 (-3.91%)

NVS Novartis
$80.94 /

-3.29 (-3.91%)

Initiation
Amgen initiated with a Neutral at UBS » 06:22
10/28/20
10/28
06:22
10/28/20
06:22
AMGN

Amgen

$223.25 /

-1.65 (-0.73%)

UBS analyst Colin Bristow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$223.25 /

-1.65 (-0.73%)

AMGN Amgen
$223.25 /

-1.65 (-0.73%)

10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
10/22/20 Oppenheimer
Amgen price target lowered to $275 from $280 at Oppenheimer
AMGN Amgen
$223.25 /

-1.65 (-0.73%)

AMGN Amgen
$223.25 /

-1.65 (-0.73%)

AMGN Amgen
$223.25 /

-1.65 (-0.73%)

AMGN Amgen
$223.25 /

-1.65 (-0.73%)

Tuesday
Hot Stocks
Amgen completes CID Pilot Program meetings with FDA regarding efavaleukin alfa » 16:15
10/27/20
10/27
16:15
10/27/20
16:15
AMGN

Amgen

$223.25 /

-1.65 (-0.73%)

Amgen announced that it…

Amgen announced that it has completed trial design discussions through two Complex Innovative Trial Designs Pilot Program meetings with the U.S. FDA for its planned Phase 2 efficacy and safety trial for efavaleukin alfa (formerly known as AMG 592), an investigational candidate for Systemic Lupus Erythematosus treatment. The CID Pilot Program aims to modernize drug development, improve efficiency, and promote innovation. The efavaleukin alfa participation in the CID Pilot Program is based on an innovative adaptive clinical trial design developed to foster the acceleration of a potential therapeutic option that could benefit patients living with SLE. "Amgen welcomes the opportunity to partner with the FDA through participation in the CID Pilot Program, which intends to advocate innovative clinical trial designs, as well as provide the FDA an opportunity to communicate these advances publicly," said Steven Galson, M.D., senior vice president, Global Regulatory Affairs and Strategy at Amgen. "We appreciate the FDA's efforts, significant contributions and feedback provided throughout the Pilot process."

ShowHide Related Items >><<
AMGN Amgen
$223.25 /

-1.65 (-0.73%)

AMGN Amgen
$223.25 /

-1.65 (-0.73%)

10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
10/22/20 Oppenheimer
Amgen price target lowered to $275 from $280 at Oppenheimer
AMGN Amgen
$223.25 /

-1.65 (-0.73%)

AMGN Amgen
$223.25 /

-1.65 (-0.73%)

AMGN Amgen
$223.25 /

-1.65 (-0.73%)

AMGN Amgen
$223.25 /

-1.65 (-0.73%)

Hot Stocks
Regenxbio to receive $80M milestone payment from Novartis » 07:17
10/27/20
10/27
07:17
10/27/20
07:17
RGNX

Regenxbio

$29.04 /

+0.29 (+1.01%)

, NVS

Novartis

$84.23 /

-0.18 (-0.21%)

Regenxbio (RGNX)…

Regenxbio (RGNX) announced that it will receive a milestone payment of $80M from Novartis (NVS) based upon the achievement of $1B in cumulative net sales of Zolgensma. Regenxbio expects to recognize this revenue in the third quarter.

ShowHide Related Items >><<
RGNX Regenxbio
$29.04 /

+0.29 (+1.01%)

NVS Novartis
$84.23 /

-0.18 (-0.21%)

RGNX Regenxbio
$29.04 /

+0.29 (+1.01%)

09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital
06/25/20 BofA
Regenxbio reinstated with a Buy at BofA
NVS Novartis
$84.23 /

-0.18 (-0.21%)

10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
RGNX Regenxbio
$29.04 /

+0.29 (+1.01%)

NVS Novartis
$84.23 /

-0.18 (-0.21%)

NVS Novartis
$84.23 /

-0.18 (-0.21%)

RGNX Regenxbio
$29.04 /

+0.29 (+1.01%)

NVS Novartis
$84.23 /

-0.18 (-0.21%)

Earnings
Novartis raises FY20 core operating income growth outlook » 06:51
10/27/20
10/27
06:51
10/27/20
06:51
NVS

Novartis

$84.23 /

-0.18 (-0.21%)

Novartis' 2020…

Novartis' 2020 guidance for continuing operations is for net sales to grow mid single digit. Core operating income view is upgraded to low double digit to mid teens, upgraded from low double digit. The company added: "The COVID-19 situation continues to evolve and is taking differing courses across the multitude of geographies that Novartis operates in. We continue to take strong actions to help address the pandemic. Our primary concerns remain the health and safety of our associates and patients. During the third quarter, overall market conditions have been recovering, though COVID-19 continues to weigh on certain therapeutic areas, most notably in dermatology, ophthalmology and the Sandoz retail business. Our operations remain stable and cash collections continue to be according to our normal trade terms, with days sales outstanding at normal levels. Novartis remains well positioned to meet its ongoing financial obligations and has sufficient liquidity to support our normal business activities. At present, drug development operations are continuing with manageable disruptions, with our range of digital technologies allowing us to proactively manage our clinical trials portfolio and rapidly mitigate any disruptions. Novartis continues to work closely with third parties to fight the COVID-19 pandemic. In September, we announced a collaboration with the African Union to facilitate the supply of COVID-19 related medicines - with a portfolio of 15 Novartis generic and over-the-counter medicines being offered at zero-profit to 55 African and 15 CARICOM eligible countries."

ShowHide Related Items >><<
NVS Novartis
$84.23 /

-0.18 (-0.21%)

NVS Novartis
$84.23 /

-0.18 (-0.21%)

10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
NVS Novartis
$84.23 /

-0.18 (-0.21%)

NVS Novartis
$84.23 /

-0.18 (-0.21%)

NVS Novartis
$84.23 /

-0.18 (-0.21%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.